Sensipar
Product Images NDC 53808-0578

6 FDA label images from State Of Florida Doh Central Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sensipar (NDC 53808-0578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (77845b3d 6c00 4855 Bf1b B83ad8b797cb 01)

Structural Formula (77845b3d 6c00 4855 Bf1b B83ad8b797cb 01)
Chemical structure of the active ingredient in Sensipar. The structure includes a trifluoromethyl group attached to a benzyl side chain, linked to an amine connected to a methylated naphthalene ring, associated with hydrochloride (HCl).*
FDA Label Image

Figure 1 (77845b3d 6c00 4855 Bf1b B83ad8b797cb 02)

Figure 1 (77845b3d 6c00 4855 Bf1b B83ad8b797cb 02)
A line graph comparing intact parathyroid hormone (iPTH) levels over 26 weeks between Sensipar and placebo groups. The y-axis shows iPTH in pg/mL, ranging from 0 to 1000, and the x-axis shows time in weeks from 0 to 26. Sensipar-treated subjects show a marked decline in iPTH levels over time, while placebo maintains steady iPTH levels. Statistical significance is indicated as P < 0.001.*
FDA Label Image

Figure 2 (77845b3d 6c00 4855 Bf1b B83ad8b797cb 03)

Figure 2 (77845b3d 6c00 4855 Bf1b B83ad8b797cb 03)
A line graph comparing the effects of Sensipar versus placebo on calcium-phosphorus product levels (Ca x P in mg/dL squared) over a 26-week period. The graph shows Sensipar with a solid line decreasing over time, while placebo, represented by a dashed line, remains relatively stable.*
FDA Label Image

Figure 3 (77845b3d 6c00 4855 Bf1b B83ad8b797cb 04)

Figure 3 (77845b3d 6c00 4855 Bf1b B83ad8b797cb 04)
A line graph depicting serum calcium levels (mg/dL) measured at three time points labeled B, T, and M for multiple subjects. The horizontal axis shows Sensipar® phases, and the vertical axis represents serum calcium concentration ranging approximately from 7.5 to 20 mg/dL. Individual subject trends are illustrated by lines connecting data points across the periods.*
FDA Label Image

Label Image For 30mg (Sensipar 30mg(amgen))

Label Image For 30mg (Sensipar 30mg(amgen))
Label for Sensipar 30 mg tablet, prescription only, with a quantity of 30 tablets. The label shows the lot number 1005198 and an expiration date of 07/31/10. It is packaged by the Florida DOH Central Pharmacy in Tallahassee, FL, and includes a barcode with a UPC number 355513073301.*
FDA Label Image

Label Image For 60mg (Sensipar 60mg(amgen))

Label Image For 60mg (Sensipar 60mg(amgen))
Label for Sensipar 60 mg tablet showing a quantity of 30 tablets. It is designated Rx only and labeled by the State of Florida DOH Central Pharmacy, Tallahassee, FL. The label includes manufacturing details by Amgen, lot number 1010007, an expiration date of 07/31/10, and a barcode with UPC 355513074308.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.